Demicco, Margherita http://orcid.org/0000-0002-9396-3281
Liu, Xiao-Zheng http://orcid.org/0000-0002-8452-6848
Leithner, Katharina http://orcid.org/0000-0002-8252-9279
Fendt, Sarah-Maria http://orcid.org/0000-0001-6018-9296
Article History
Received: 12 July 2022
Accepted: 6 December 2023
First Online: 24 January 2024
Competing interests
: S.-M.F. has received funding from Gilead, Auron Therapeutics, Black Belt Therapeutics and Alesta Therapeutics, has consulted for Fund+ and is on the advisory board of Alesta Therapeutics. All other authors declare no competing interests.